We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Technology Enables Precise Drug Delivery to Brain Using Ultrasound

By MedImaging International staff writers
Posted on 08 Feb 2017
Image: The new technology uses non-invasive ultrasound waves to deliver drug-laden nano-particles (left) with a liquid center (green) that turns to gas and releases the therapeutic drug (blue) (Photo courtesy of Raag Airan).
Image: The new technology uses non-invasive ultrasound waves to deliver drug-laden nano-particles (left) with a liquid center (green) that turns to gas and releases the therapeutic drug (blue) (Photo courtesy of Raag Airan).
Researchers have demonstrated that they can use ultrasound pulses to activate the release of drugs from nanoparticles in the brain of laboratory animals.

The researchers released the concentrated drug doses temporarily in specific localized regions of the brain from inside minute biodegradable "nanoparticles" by means of precisely targeted ultrasound waves.

According to the researchers from the Johns Hopkins University School of Medicine, the method could be used to deliver most psychoactive and other drugs, and advance therapies and research studies for the brain and other organs. The research results were published in on January 23, 2017, in the journal Nano Letters.

The new method could reduce the side effects of drugs considerable, because of the way it releases a much lower but concentrated dose a drug in a specific region. This results in a much lower overall drug doses for the patient during therapy treatment. The technology uses biomaterials, drugs approved by the US FDA, and ultrasound methods that have been tested, and found to be safe for humans. The researchers hope to start the regulatory approval process of their new technology for clinical applications within one or two years.

Associate professor of biomedical engineering, Jordan Green, PhD, said, "If further testing of our combination method works in humans, it will not only give us a way to direct medications to specific areas of the brain, but will also let us learn a lot more about the function of each brain area."

Biopsy Software
Affirm® Contrast
New
High-Precision QA Tool
DEXA Phantom
40/80-Slice CT System
uCT 528
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector

Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.